Sonia Guedan, Cancer Immunologist at Hospital Clinic Barcelona, shared a post on X:
“TECELRA (afamitresgene autoleucel) has become the first engineered cell therapy for a solid tumor cancer approved by the U.S. FDA.
Congratulations to Adaptimmune and everyone involved in achieving this incredible milestone!“
Read further.
Source: Sonia Guedan/X